Literature DB >> 23436721

Pramipexole-induced disruption of behavioral processes fundamental to intertemporal choice.

Patrick S Johnson1, Jeffrey S Stein, Rochelle R Smits, Gregory J Madden.   

Abstract

Evaluating the effects of presession drug administration on intertemporal choice in nonhumans is a useful approach for identifying compounds that promote impulsive behavior in clinical populations, such as those prescribed the dopamine agonist pramipexole (PPX). Based on the results of previous studies, it is unclear whether PPX increases rats' impulsive choice or attenuates aspects of stimulus control. The present study was designed to experimentally isolate behavioral processes fundamental to intertemporal choice and challenge them pharmacologically with PPX administration. In Experiment 1, the hypothesis that PPX increases impulsive choice as a result of enhanced sensitivity to reinforcer delays was tested and disconfirmed. That is, acute PPX diminished delay sensitivity in a manner consistent with disruption of stimulus control whereas repeated PPX had no effect on delay sensitivity. Experiments 2 and 3 elaborated upon this finding by examining the effects of repeated PPX on rats' discrimination of response-reinforcer contingencies and reinforcer amounts, respectively. Accuracy of both discriminations was reduced by PPX. Collectively these results provide no support for past studies that have suggested PPX increases impulsive choice. Instead, PPX impairs stimulus control over choice behavior. The behavioral approach adopted herein could be profitably integrated with genetic and other biobehavioral models to advance our understanding of impulsive behavior associated with drug administration. © Society for the Experimental Analysis of Behavior.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23436721      PMCID: PMC4161207          DOI: 10.1002/jeab.21

Source DB:  PubMed          Journal:  J Exp Anal Behav        ISSN: 0022-5002            Impact factor:   2.468


  47 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

2.  Delay discounting is associated with treatment response among cocaine-dependent outpatients.

Authors:  Yukiko Washio; Stephen T Higgins; Sarah H Heil; Todd L McKerchar; Gary J Badger; Joan M Skelly; Robert L Dantona
Journal:  Exp Clin Psychopharmacol       Date:  2011-06       Impact factor: 3.157

3.  A progression for generating variable-interval schedules.

Authors:  M FLESHLER; H S HOFFMAN
Journal:  J Exp Anal Behav       Date:  1962-10       Impact factor: 2.468

4.  Analysis of effects of psychopharmacological agents in behavioral terms.

Authors:  P B DEWS
Journal:  Fed Proc       Date:  1958-12

5.  The optimal correction for estimating extreme discriminability.

Authors:  Glenn S Brown; K Geoffrey White
Journal:  Behav Res Methods       Date:  2005-08

6.  Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease.

Authors:  Jee-Young Lee; Eun Kyung Lee; Sung Sup Park; Ji-Yeon Lim; Hee Jin Kim; Ji Sun Kim; Beom S Jeon
Journal:  Mov Disord       Date:  2009-09-15       Impact factor: 10.338

7.  Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.

Authors:  Annamaria Vallelunga; Raffaella Flaibani; Patrizia Formento-Dojot; Roberta Biundo; Silvia Facchini; Angelo Antonini
Journal:  Parkinsonism Relat Disord       Date:  2011-11-22       Impact factor: 4.891

8.  Delay discounting predicts adolescent substance abuse treatment outcome.

Authors:  Catherine Stanger; Stacy R Ryan; Hongyun Fu; Reid D Landes; Bryan A Jones; Warren K Bickel; Alan J Budney
Journal:  Exp Clin Psychopharmacol       Date:  2011-12-19       Impact factor: 3.157

9.  Effects of selective dopaminergic compounds on a delay-discounting task.

Authors:  Mikhail N Koffarnus; Amy H Newman; Peter Grundt; Kenner C Rice; James H Woods
Journal:  Behav Pharmacol       Date:  2011-08       Impact factor: 2.293

10.  Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain.

Authors:  Olga Chernoloz; Mostafa El Mansari; Pierre Blier
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

View more
  4 in total

Review 1.  Dissecting drug effects in preclinical models of impulsive choice: emphasis on glutamatergic compounds.

Authors:  Justin R Yates
Journal:  Psychopharmacology (Berl)       Date:  2018-01-06       Impact factor: 4.530

2.  Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release.

Authors:  Romina Pes; Sean C Godar; Andrew T Fox; Lauren M Burgeno; Hunter J Strathman; David P Jarmolowicz; Paola Devoto; Beth Levant; Paul E Phillips; Stephen C Fowler; Marco Bortolato
Journal:  Neuropharmacology       Date:  2016-11-23       Impact factor: 5.250

3.  Impulsive choice, alcohol consumption, and pre-exposure to delayed rewards: II. Potential mechanisms.

Authors:  Jeffrey S Stein; C Renee Renda; Jay E Hinnenkamp; Gregory J Madden
Journal:  J Exp Anal Behav       Date:  2014-11-23       Impact factor: 2.468

4.  Effects of N-methyl-d-aspartate receptor (NMDAr) uncompetitive antagonists in a delay discounting paradigm using a concurrent-chains procedure.

Authors:  Justin R Yates; Benjamin T Gunkel; Katherine K Rogers; Kerry A Breitenstein; Mallory N Hughes; Anthony B Johnson; Sara M Sharpe
Journal:  Behav Brain Res       Date:  2018-03-28       Impact factor: 3.332

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.